Tudor Investment Corp’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-23,531
Closed -$39.5K 3058
2024
Q2
$39.5K Buy
+23,531
New +$42.2K ﹤0.01% 2236
2024
Q1
Sell
-47,101
Closed -$72.1K 2643
2023
Q4
$72.1K Hold
47,101
﹤0.01% 2256
2023
Q3
$51.3K Sell
47,101
-1,484
-3% -$2.6K ﹤0.01% 2179
2023
Q2
$111K Buy
48,585
+37,585
+342% +$99.8K ﹤0.01% 2289
2023
Q1
$27K Buy
+11,000
New +$25.2K ﹤0.01% 2302
2022
Q3
Sell
-105,106
Closed -$195K 2620
2022
Q2
$195K Sell
105,106
-34,495
-25% -$65.8K 0.01% 1830
2022
Q1
$292K Sell
139,601
-11,347
-8% -$31.5K 0.01% 1568
2021
Q4
$595K Buy
150,948
+42,407
+39% +$206K 0.01% 1336
2021
Q3
$522K Buy
108,541
+93,480
+621% +$384K 0.01% 1623
2021
Q2
$69K Buy
+15,061
New +$72.5K ﹤0.01% 1543
2020
Q4
Sell
-18,034
Closed -$26K 1508
2020
Q3
$26K Sell
18,034
-17,150
-49% -$30.5K ﹤0.01% 1227
2020
Q2
$70K Sell
35,184
-89
-0.3% -$174 ﹤0.01% 1097
2020
Q1
$69K Buy
+35,273
New +$105K 0.01% 954
2017
Q4
Sell
-14,406
Closed -$177K 1186
2017
Q3
$177K Buy
+14,406
New +$213K 0.01% 976
2017
Q2
Sell
-25,827
Closed -$370K 1222
2017
Q1
$370K Sell
25,827
-4,747
-16% -$70.4K 0.01% 865
2016
Q4
$423K Sell
30,574
-11,276
-27% -$181K 0.02% 808
2016
Q3
$756K Buy
41,850
+29,499
+239% +$475K 0.03% 528
2016
Q2
$177K Buy
+12,351
New +$168K 0.01% 1435
2015
Q4
Sell
-15,299
Closed -$164K 1777
2015
Q3
$164K Buy
+15,299
New +$167K 0.01% 1375
2015
Q2
Sell
-4,175
Closed -$28K 1593
2015
Q1
$28K Sell
4,175
-3,439
-45% -$23.5K ﹤0.01% 1413
2014
Q4
$48K Buy
7,614
+3,439
+82% +$27.7K ﹤0.01% 1399
2014
Q3
$41K Buy
4,175
+655
+19% +$6.99K ﹤0.01% 1311
2014
Q2
$40K Hold
3,520
﹤0.01% 1128
2014
Q1
$43K Sell
3,520
-961
-21% -$12.3K ﹤0.01% 1156
2013
Q4
$56K Buy
+4,481
New +$71.3K ﹤0.01% 1231

Other funds holding LXRX